January 17, 2017
Imedex Certifies a Critical Review of Data Presented at Annual Breast Cancer Symposium During the 14th Annual Best of San Antonio: Breast Cancer – Bench to Bedside
(Chicago, IL) — For breast cancer clinicians and researchers who were unable to attend the 2016 San Antonio Breast Cancer Symposium (SABCS) or those who desire a more intimate review and analysis of its highlights, a novel half-day, complimentary meeting—the 14th Annual Best of San Antonio: Breast Cancer – Bench to Bedside—is being offered by Imedex on February 4, 2017 in Chicago. Chaired by Kathy S. Albain, MD, FACP, FASCO from the Loyola University Chicago Stritch School of Medicine in Maywood, Illinois. Bench to Bedside addresses the educational needs of clinicians who provide clinical care to patients with breast cancer.
For the most part, results presented at SABCS are not yet published, yet many are ripe for incorporation into practice standards. Bench to Bedside encourages with this translation from research to practice. “Community and academic clinicians rely on this meeting each year to analyze results and have them discussed within the context of daily breast cancer practice. This meeting fills a major gap in learning for the participants, as evidenced by the many who return year after year, said Dr. Albain.
With an all-star faculty line-up, including the chair, Suzanne A.W. Fuqua, PhD (Houston, TX), Constantine Godellas, MD, FACS (Maywood, IL), Dawn L. Hershman, MD, MS (New York, NY), Hope S. Rugo, MD (San Francisco, CA), Debu Tripathy, MD (Houston, TX) and Eric P. Winer, MD (Boston, MA), the half-day agenda includes discussion on updates in novel therapeutics, neoadjuvant and adjuvant approaches, predictive biomarkers, prevention and survivorship care. The complete agenda is available at www.breastcancerbenchtobedside.com.
The meeting, held in the Midwest, is certified and organized by Imedex, an industry leader in providing live and online oncology CME. Imedex is pleased to once again provide this complimentary, educational program to the breast cancer community. For more information and to register, please visit www.breastcancerbenchtobedside.com.
Imedex is the industry leader in developing and delivering independent, accredited healthcare education. The Company’s programs specializing in hematology, oncology, and gastroenterology are provided through live events around the world as well as through effective online educational opportunities for on-the-go healthcare providers.
Imedex’s high-quality scientific programming translates the latest research into clinically relevant information. Our activities facilitate the needs of time-constrained healthcare professionals who are inundated by information through exceptional organization and outstanding educational value — all with a proven and sustained impact on patient care.
Imedex provides over 50,000 E-learning experiences annually and its live conferences have welcomed more than 100,000 attendees since 2001. The Company has a global footprint and operates in the United States, Europe, and Asia.
At Imedex, we believe education is the best medicine®. For more information on Imedex and upcoming conferences, visit us online at http://www.imedex.com, on our E-learning Center at http://elc.imedex.com, or via email at firstname.lastname@example.org.
Other upcoming Imedex events:
Great Debates & Updates in GI Malignancies
March 24-25, 2017 | New York, New York
Wyndham New Yorker Hotel
Great Debates & Updates in Hematologic Malignancies
April 7-8, 2017 | New York, New York
New York Marriott Downtown